Core Points - The company announced that it will hold the 23rd meeting of the fifth board of directors on November 11, 2025, to review a proposal for providing guarantee limits for its subsidiaries [1] - The total guarantee amount for the subsidiaries, including Shanghai Selis Medical Technology Co., Ltd., Selis Biological Technology Co., Ltd., and Huali Zhiwei (Shanghai) Diagnostic Technology Co., Ltd., is expected to be no more than RMB 80 million [1] - The guarantees will be provided in various forms, including but not limited to guarantees, pledges, and mortgages, with the actual guarantee amount and duration to be determined by the final signed agreement [1] - The expected validity period for the guarantees is within twelve months after the board's approval [1] - There are no counter-guarantees required for the subsidiaries being guaranteed, as they are all controlled subsidiaries of the company [1]
塞力医疗:关于为控股子公司提供担保额度预计的公告